OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 22,500 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 22,500 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $23.35, for a total value of $525,375.00. Following the sale, the insider directly owned 6,504,133 shares of the company’s stock, valued at approximately $151,871,505.55. This represents a 0.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Friday, August 28th, Squadron Capital Llc sold 326,700 shares of OrthoPediatrics stock. The shares were sold at an average price of $23.04, for a total transaction of $7,527,168.00.
• On Tuesday, September 1st, Squadron Capital Llc sold 10,131 shares of OrthoPediatrics stock. The stock was sold at an average price of $23.10, for a total transaction of $234,026.10.
• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.28, for a total transaction of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.74, for a total transaction of $403,262.00.
• On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $25.75, for a total transaction of $103,000.00.

OrthoPediatrics Stock Performance

NASDAQ KIDS traded down $0.18 during trading hours on Friday, hitting $22.41. 129,506 shares of the stock were exchanged, compared to its average volume of 173,525. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. The company has a market cap of $585.13 million, a price-to-earnings ratio of -13.34 and a beta of 0.99. OrthoPediatrics Corp. has a 12-month low of $14.42 and a 12-month high of $26.74. The stock has a 50-day moving average of $21.74 and a 200 day moving average of $18.84.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.04. The company had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. As a group, equities research analysts forecast that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Millennium Management LLC raised its position in shares of OrthoPediatrics by 48.0% in the fourth quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after buying an additional 452,840 shares during the last quarter. BlackRock Inc. purchased a new stake in OrthoPediatrics in the 2nd quarter worth approximately $24,347,000. Vanguard Group Inc. raised its holdings in OrthoPediatrics by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock valued at $17,813,000 after acquiring an additional 10,927 shares during the last quarter. Granahan Investment Management LLC raised its holdings in OrthoPediatrics by 35.1% in the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock valued at $14,231,000 after acquiring an additional 232,760 shares during the last quarter. Finally, Wasatch Advisors LP lifted its stake in shares of OrthoPediatrics by 56.6% during the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after purchasing an additional 186,357 shares during the period. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on KIDS. Needham & Company LLC upped their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Piper Sandler restated an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. BTIG Research boosted their price target on OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a research note on Thursday, August 20th. Finally, Weiss Ratings raised OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.